- Home
- SBFM vs GNPX Comparison
SBFM vs GNPX Comparison
Compare SBFM & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- GNPX
- Stock Information
- Founded
- SBFM 2006
- GNPX 2009
- Country
- SBFM United States
- GNPX United States
- Employees
- SBFM N/A
- GNPX N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- GNPX Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- GNPX Health Care
- Exchange
- SBFM Nasdaq
- GNPX Nasdaq
- Market Cap
- SBFM 6.5M
- GNPX 7.4M
- IPO Year
- SBFM N/A
- GNPX 2018
- Fundamental
- Price
- SBFM $1.49
- GNPX $0.21
- Analyst Decision
- SBFM Strong Buy
- GNPX
- Analyst Count
- SBFM 1
- GNPX 0
- Target Price
- SBFM $15.00
- GNPX N/A
- AVG Volume (30 Days)
- SBFM 54.6K
- GNPX 1.1M
- Earning Date
- SBFM 08-12-2025
- GNPX 08-14-2025
- Dividend Yield
- SBFM N/A
- GNPX N/A
- EPS Growth
- SBFM N/A
- GNPX N/A
- EPS
- SBFM N/A
- GNPX N/A
- Revenue
- SBFM $36,341,741.00
- GNPX N/A
- Revenue This Year
- SBFM $32.20
- GNPX N/A
- Revenue Next Year
- SBFM $32.74
- GNPX N/A
- P/E Ratio
- SBFM N/A
- GNPX N/A
- Revenue Growth
- SBFM 19.22
- GNPX N/A
- 52 Week Low
- SBFM $1.17
- GNPX $0.20
- 52 Week High
- SBFM $3.90
- GNPX $3.97
- Technical
- Relative Strength Index (RSI)
- SBFM 51.16
- GNPX 38.92
- Support Level
- SBFM $1.35
- GNPX $0.21
- Resistance Level
- SBFM $1.52
- GNPX $0.24
- Average True Range (ATR)
- SBFM 0.08
- GNPX 0.02
- MACD
- SBFM 0.01
- GNPX -0.00
- Stochastic Oscillator
- SBFM 66.30
- GNPX 10.41
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.